Your browser doesn't support javascript.
loading
Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.
Sigaroudi, Ali; Kullak-Ublick, Gerd A; Weiler, Stefan.
Afiliação
  • Sigaroudi A; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
  • Weiler S; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. stefan.weiler@usz.ch.
Eur J Clin Pharmacol ; 72(3): 377-8, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26631062
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Carbamazepina / Antibacterianos / Anticonvulsivantes Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Carbamazepina / Antibacterianos / Anticonvulsivantes Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article